SCHEMBL16587727

SCHEMBL16587727

CCOC(=O)N1CCCC(C(C)C)C1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ ALDH1A1 P00352 5/20 0.46
▸ CASP6 P55212 1/20 0.46
▸ GAA P10253 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ HTT P42858 1/20 0.43
▸ TSHR P16473 2/20 0.42
▸ CHRM1 P11229 1/20 0.42
▸ HCRTR2 O43614 1/20 0.42
▸ HPGD P15428 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12384857 1.00 THRB (0.49) THRBATML3MBTL1ALDH1A1CASP6
SCHEMBL12142025 0.92 GAA (0.53) THRBATML3MBTL1ALDH1A1CASP6
SCHEMBL26461748 0.92 GAA (0.53) THRBATML3MBTL1ALDH1A1CASP6
SCHEMBL22971690 0.83 CYP1A2 (0.41) ALDH1A1TSHRHPGD
SCHEMBL12384735 0.83 CYP1A2 (0.41) ALDH1A1TSHRHPGD
SCHEMBL4762356 0.81 GAA (0.61) THRBATML3MBTL1ALDH1A1CASP6
SCHEMBL15827186 0.80 EPHX2 (0.44) ALDH1A1GAAKDM4EPOLBTSHR
SCHEMBL12384822 0.80 EPHX2 (0.44) ALDH1A1GAAKDM4EPOLBTSHR
SCHEMBL17084106 0.80 SMN1; SMN2 (0.55) HTTNPC1RAB9ASMN1; SMN2
SCHEMBL16980450 0.80 SMN1; SMN2 (0.55) HTTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8987268-B2 Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases BRISTOL-MYERS SQUIBB COMPANY (US) 2015-03-24 — — US disclosed
Send feedback